MYC and Miyoshi myopathy: Several oncogenic drivers responsible for the progression of clonal PCs from an indolent MGUS phase to malignant MM have been identified such as MYC structural variants, activating mutations of RAS and NF-kB pathways, mutations of DIS3 or FAM46C etc4.